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ABSTRACT
Objectives: This study aimed to determine whether ad-
vanced age or sex was predictive of adverse outcomes
after Roux-en-Y gastric bypass.
Methods: The Pennsylvania State Discharge Database
was searched for records of morbidly obese patients who
underwent Roux-en-Y gastric bypass. The SASs MIXED
Procedure was used to test whether mortality alone or
adverse outcomes (postoperative complications, nonrou-
tine hospital transfer and mortality) were significantly re-
lated to sex or advanced age (50 years). The presence of
comorbidities was used as a blocking variable.
Results: Between 1999 and 2001, 4,685 patients under-
went Roux-en-Y gastric bypass in Pennsylvania, of which
82% were female and 20% were older than 50 years of age.
Comorbidities were present in 71% of patients. Twenty-
eight deaths (0.6%) and 813 adverse outcomes (17.4%)
occurred. Mortality was greater in males than in females
(1.2% vs. 0.47%, P0.05) without comorbid interaction.
Mortality did not increase with age. Adverse outcomes
were related to both sexes (24% male, 16% female,
P0.05) and age (50, 16% vs. 50, 23%, P0.05) with a
small comorbid interaction.
Conclusion: Adverse outcomes are more frequent
among males and older patients and are influenced by
comorbidities. Male patients have a higher mortality that
was not affected by the presence of comorbidities.
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INTRODUCTION
Obesity has reached epidemic proportions in the United
States and has become a major health problem estimated
to account for approximately 280,000 deaths per year.1
Bariatric surgery has been proven to be the most effective
treatment of refractory morbid obesity. Roux-en-Y gastric
bypass (RYGB) appears to offer the best long-term results,
and the demand for this procedure has increased dramat-
ically the last decade.2 The elective nature of this proce-
dure mandates a low risk/benefit ratio. Identification of
risk factors that predict adverse outcomes after RYGB and
preoperative risk stratification is an integral part of patient
education and selection and ultimately leads to improved
patient satisfaction. Hypertension, sleep apnea, advanced
age, sex, and surgeon’s experience have all been associ-
ated with adverse outcome after RYGB in recent stud-
ies.3–5 The main limitation of these studies is that they
represent a single institution’s experience. Our popula-
tion-based study includes all patients who underwent
RYGB in the State of Pennsylvania over a 3-year period
and aims to determine whether age or sex is predictive of
adverse outcomes and mortality.
METHODS
All hospitals in the state of Pennsylvania are required to
review all in-patient hospital medical records and submit
data regarding patients’ age, sex, race, principal and all
secondary diagnoses, principal and all secondary proce-
dures, length of stay, illness severity, discharge status,
unique hospital and surgeon identifier, and insurance
status to the Pennsylvania Health Care Cost Containment
Council (PHC4) on a quarterly basis. Data are abstracted
from medical records and collection is made by trained
personnel in each hospital and is based on standardized
requirements. The principal procedure code for RYGB
(44.31 or 44.39) and the principal diagnosis code for
obesity (diagnostic-related group 288) were used to
search the PHC4 database and identify patients who un-
derwent RYGB for obesity between January 1, 1999 and
December 31, 2001.
Data regarding age, sex, race, comorbid medical condi-
tions, illness severity, in-hospital mortality, in-hospital ad-
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SCIENTIFIC PAPERverse outcome, and insurance status for all appropriately
selected patients were obtained from the database. Preva-
lences were computed, and subsequent analysis with the
MIXED Procedure6 (SAS Institute Inc., Cary, NC) was used
to assess whether advanced age (50 years) or sex sig-
nificantly increase mortality or adverse outcomes after
RYGB for obesity while controlling for any comorbid
medical conditions. The dependent variables were in-
hospital mortality and adverse outcome. In-hospital ad-
verse outcome was defined as a combined variable (one
or more postoperative complications, nonroutine hospital
transfer, and in-hospital mortality). Complications or
deaths that occurred after discharge from the original
hospitalization for surgery could not be identified based
on the collected data and therefore are not reported.
Nonroutine hospital transfer is defined as any disposition
other than discharge to home. The independent variables
included patient age, sex, race, comorbid medical condi-
tions, insurance status, and illness severity. Co-morbidities
included the secondary diagnoses of all the obesity-re-
lated medical conditions, such as sleep apnea, hypercho-
lesterolemia, cirrhosis, history of thrombophlebitis, coro-
nary artery disease, diabetes mellitus, hypertension,
osteoarthritis, benign intracranial hypertension, esopha-
geal reflux, depression, and congestive heart failure. Pa-
tient’s preoperative illness severity was categorized as
catastrophic, major, moderate, or minor, according to the
Ohio Refined DRG Grouper, a Severitized DRG Report.7
RESULTS
Between 1999 and 2001, 4685 patients in Pennsylvania
underwent RYGB for obesity. Of the 4685 patients, 82%
were females and the remaining were males. Ages ranged
from 16 to 74 years with a mean and median of 42 years.
Included were 3076 (80%) patients 50 years or younger
(mean age, 38 years) and 609 patients older than 50 years
(mean age, 55 years). No change occurred in the annual
ratios of female/male and younger/older patients between
1999 and 2001. Seventy percent of patients were white
and 10% were black. The race was not coded in the
remaining 20%. Patient’s preoperative illness severity was
categorized as catastrophic in 4.5%, major in 16.3%, mod-
erate in 16.2%, and minor in 63% of cases. Seventy-one
percent of patients had one or more comorbid medical
conditions (Table 1).
The median length of stay was 4 days (range, 1 to 83). An
in-hospital adverse outcome occurred in 813 of 4685
(17.4%) patients who underwent RYGB. Of the 813 pa-
tients with adverse outcomes, 756 (93%) had postopera-
tive complications, 29 (3.6%) required a nonroutine hos-
pital transfer, and 28 (3.4%) died in the immediate
postoperative period. The overall complication and mor-
tality rates were 16.1% (756/4685) and 0.6% (28/4685),
respectively. Respiratory complications were the most
common (7.7%) followed by cardiac events (3.4%), intes-
tinal obstruction (2.7%), urinary complications (2.6%),
hemorrhage (2.4%), sepsis (1.9%), renal failure (0.8%),
pulmonary embolism (0.2%), clostridium difficile colitis
(0.2%) and fascial dehiscence (0.1%). Patients with major
or catastrophic illness severity preoperatively had the
highest prevalence (71.5%) of adverse outcome, while
patients with Medicaid insurance had the highest mortality
rate (1.6%). Age 50 years, male sex, black race, and
presence of comorbidities were also associated with an
increased prevalence of adverse outcomes and mortality
(Table 2).
Male patients had a significantly higher prevalence of
adverse outcomes (males, 24% vs. females, 16%, P0.05)
and mortality (males, 1.2% vs. females, 0.47%, P0.05)
(Figures 1 and 2). The likelihood of an adverse outcome in
males was further increased (P0.05) when the groups
were controlled for the presence of comorbid medical
conditions (Figure 1). Older patients had a significantly
higher adverse outcome rate (50, 23% vs. 50, 16%,
P0.05) as well. Adverse outcome rates were higher
(P0.05) in older patients who had no other comorbid
medical conditions (Figure 3). Age had no significant
effect on mortality rates (Figure 4). The presence of co-
morbidities had no significant effect on mortality rate in
relation to sex or age.
Table 1.
Incidence of Comorbid Medical Conditions
Condition %
Hypertension 41%
Sleep apnea 25%
Gastroesophageal reflux disease 23%
Diabetes mellitus 19%
Osteoarthritis 12%
Depression 11%
Hypercholesterolemia 9%
Coronary artery disease 2.6%
Congestive heart failure 1.6%
Cirrhosis 0.5%
Benign intracranial hypertension 0.5%
Venous stasis 0.1%
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Statewide data from Pennsylvania confirmed the national
trend of an increasing demand for bariatric procedures.8
In this study, the annual number of patients undergoing
RYGB almost doubled each year (672 in 1999, 1322 in
2000, 2691 in 2001). In accordance with the literature,9 the
majority of patients in this study undergoing RYGB were
females less than 50 years old and of white origin. Ap-
proximately 2/3 of patients had additional obesity-related
comorbidities and 1/5 was considered severely ill preop-
eratively. In addition, the 16.1% and 0.6% complication
and mortality rates reported in this study fall within the
range of rates reported in previous open9 and laparo-
scopic10 RYGB series.
According to our results, men carry a higher risk for
postoperative complications and death after RYGB. The
complication rate in male patients undergoing RYGB was
further increased when additional comorbid medical con-
ditions were present. Mortality rate in male patients how-
ever was not related to pre-existing medical conditions.
Recent studies have also shown that male sex is an inde-
pendent risk factor for complications and anastomotic
leaks.4,10–12 Livingston et al12 showed in his series of 1067
patients that adverse outcomes after RYGB occurred more
frequently in men (men, 13.1% vs. women, 6%).
Table 2.
Patient Characteristics With Increased Prevalence of Adverse
Outcome and Mortality
Patient Characteristics Adverse
Outcome (%)
Mortality
(%)
Major or catastrophic
illness severity
71.5% (696/973) 0.6% (6/973)
Medicaid insurance 24.7% (94/381) 1.6% (6/381)
Male sex 23.9% (199/833) 1.2% (10/833)
Age 50 years 23.2% (222/957) 0.6% (6/957)
Black race 18.2% (82/451) 1.3% (6/451)
Comorbid medical
conditions
18.2% (608/3340) 0.5% (17/3340)
Figure 1. Prevalence of adverse outcome in relation to sex, with
or without comorbidity interaction. CMC  Comorbid medical
conditions,
*P0.05.
Figure 2. Mortality rate in relation to sex.
*P0.05.
Figure 3. Prevalence of adverse outcome in relation to age,
with, or without comorbidity interaction. CMC  Comorbid
medical conditions,
*P0.05.
Figure 4. Mortality rate in relation to age.
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age significantly increased the likelihood of complications
after RYGB. In addition, as previously reported,4 the pres-
ence of comorbid medical conditions in older patients
undergoing RYGB did not have a negative impact on the
morbidity of the procedure. Our finding, however, that
mortality rates were similar in younger and older patients,
is in contrast with the study by Livingston et al11 that
showed that mortality of patients 55 years of age and older
was 3.5% compared with 1.1% in patients younger than 55
years (P0.05). It is possible that the different cut-off
values used in the 2 studies to dichotomize the age vari-
able may have affected the ultimate results of the analysis.
This study has certain advantages. Contrary to most of the
published series that represent a single institution’s expe-
rience, this is a large, population-based study including
surgeons and institutions from the entire State of Pennsyl-
vania. Therefore, the applicability of the findings is more
likely to be generalizable to all practice settings. The
inclusion of nonroutine hospital transfers to the in-hospi-
tal adverse outcomes allowed the identification of all pa-
tients who experienced a less than routine outcome after
elective surgery. Furthermore, in this study, the effect of
comorbid medical conditions on the relationship of age
and sex to the morbidity and mortality of RYGB was
statistically controlled. Previous studies, such as that by
Nguyen and colleagues,4 have not done so.
This study also has several limitations. Body mass index
(BMI) was not included in the data reported to the PHC4
by each hospital. Therefore, the effect of the BMI-age, or
BMI-sex interaction on the morbidity and mortality rates is
not known. Nevertheless, BMI was not a significant risk
factor for an adverse outcome after RYGB in any of the
previously published reports.3,4,11,12 Similarly, the anasto-
motic leak rate was not separately recorded and therefore
could not be assessed.
In addition, laparoscopic and open RYGB could not be
distinguished in the state database and could not be ana-
lyzed separately. As a result, the effect of type of approach
on the increased morbidity and mortality of RYGB in
patients of advanced age or male sex cannot be investi-
gated. A recent study showed that the laparoscopic ap-
proach did not ameliorate the increased risk of men for
postoperative complications. In his series of 150 laparo-
scopic RYGB, Nguyen et al4 demonstrated that men had a
greater risk of developing complications (adjusted odds
ratio, 5.2, P0.03) than did women. In contrast, another
recent study of 188 laparoscopic RYGB by Perugini et al3
showed that of 9 variables examined by univariate and
multivariate analysis, including age and sex, only sur-
geon’s experience, sleep apnea, and hypertension were
predictive of complications. Further studies on larger pa-
tient populations are needed to delineate the effect, if any,
of the type of approach on the increased morbidity and
mortality of RYGB in older men.
It was also impossible to distinguish primary and revision
RYGB in the database. Major complications following re-
vision operations have been more frequent than in pri-
mary RYGB in most reported series.13,14 Others however
found no significant increase in the complication rates
after revision RYGB.12 Nevertheless, it is possible that the
inclusion of revision operations in this study may have
affected the reported morbidity and mortality rate. An-
other limitation of this study is that the complication and
mortality rates represent events that occurred within the
initial in-hospital course from the day of surgery until the
date of discharge. Discharge data collection and entry did
not allow the identification of events that occurred during
the 30-day postoperative period but after the initial dis-
charge. Therefore, it is likely that the complication and
mortality rates reported herein might have been underes-
timated. Finally, the coding of data for these databases
may lead to systematic over- or underreporting.15
CONCLUSION
In summary, this study clearly suggests that male patients
are at increased risk for complications and death after
RYGB and should be monitored closely during the imme-
diate postoperative period. Careful preoperative patient
assessment for any comorbid medical conditions is impor-
tant for risk stratification purposes, especially for men,
because their presence increases the morbidity of the
procedure. Older patients require close perioperative
monitoring as well because advanced age (50 years) has
a negative impact on morbidity rates after RYGB. Despite
the fact that the morbidity and mortality rates after RYGB
remain within acceptable limits for both subgroups, older
patients and men should be counseled regarding their
higher perioperative risk.
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